Insider Buy/Sell Ratio — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Consumer Cyclical
Buys51
Sells699
Buy $$24.07M
Sell $$2.61B
Ratio1:108.23
% Change vs. Prior
Ratio +35.8%Value +81.0%
Technology
Buys147
Sells2666
Buy $$84.13M
Sell $$2.44B
Ratio1:29.02
% Change vs. Prior
Ratio -89.2%Value -51.0%
Financial Services
Buys305
Sells1103
Buy $$430.20M
Sell $$1.73B
Ratio1:4.03
% Change vs. Prior
Ratio +394.2%Value +219.4%
Healthcare
Buys166
Sells1390
Buy $$64.64M
Sell $$1.61B
Ratio1:24.87
% Change vs. Prior
Ratio +169.7%Value -46.3%
Consumer Defensive
Buys41
Sells196
Buy $$9.10M
Sell $$1.19B
Ratio1:131.00
% Change vs. Prior
Ratio -85.0%Value +31.5%
Energy
Buys54
Sells185
Buy $$20.88M
Sell $$980.86M
Ratio1:46.98
% Change vs. Prior
Ratio +74.2%Value +21.1%
Industrials
Buys113
Sells642
Buy $$131.88M
Sell $$797.09M
Ratio1:6.04
% Change vs. Prior
Ratio +120.8%Value +31.7%
Communication Services
Buys35
Sells245
Buy $$30.52M
Sell $$309.09M
Ratio1:10.13
% Change vs. Prior
Ratio -47.5%Value +48.1%
Basic Materials
Buys42
Sells75
Buy $$3.57M
Sell $$54.24M
Ratio1:15.19
% Change vs. Prior
Ratio +68.1%Value -73.9%
Real Estate
Buys57
Sells64
Buy $$14.05M
Sell $$42.15M
Ratio1:3.00
% Change vs. Prior
Ratio +685.8%Value +20.9%
Utilities
Buys17
Sells34
Buy $$3.42M
Sell $$11.67M
Ratio1:3.42
% Change vs. Prior
Ratio +111.2%Value -79.0%
By Industry
Beverages - Non-Alcoholic
Buys3
Sells11
Buy $$2.01M
Sell $$1.07B
Ratio1:532.39
Asset Management
Buys65
Sells87
Buy $$72.17M
Sell $$670.76M
Ratio1:9.29
Leisure
Buys3
Sells45
Buy $$746.99K
Sell $$718.54M
Ratio1:961.91
Biotechnology
Buys103
Sells747
Buy $$42.09M
Sell $$643.99M
Ratio1:15.30
% Change vs. Prior
Ratio +329.5%Value -70.8%
Software - Application
Buys81
Sells651
Buy $$79.83M
Sell $$591.65M
Ratio1:7.41
% Change vs. Prior
Ratio +73.7%Value -40.4%
Software - Infrastructure
Buys9
Sells921
Buy $$158.57K
Sell $$596.33M
Ratio1:3760.59
% Change vs. Prior
Ratio -92.1%Value -23.4%
Specialty Retail
Buys13
Sells284
Buy $$3.41M
Sell $$589.20M
Ratio1:172.72
% Change vs. Prior
Ratio +105.2%Value -30.5%
Oil & Gas Equipment & Services
Buys5
Sells53
Buy $$4.27M
Sell $$516.88M
Ratio1:121.09
Travel Services
Buys0
Sells79
Buy $$0.00
Sell $$511.38M
RatioAll Sells
Computer Hardware
Buys0
Sells359
Buy $$0.00
Sell $$490.26M
RatioAll Sells
% Change vs. Prior
Ratio NaN%Value -16.0%
Financial - Capital Markets
Buys14
Sells146
Buy $$322.12M
Sell $$162.52M
Ratio1.98:1
Banks - Regional
Buys134
Sells478
Buy $$15.25M
Sell $$388.91M
Ratio1:25.51
Medical - Diagnostics & Research
Buys5
Sells315
Buy $$1.14M
Sell $$344.07M
Ratio1:302.53
Auto - Dealerships
Buys6
Sells24
Buy $$1.55M
Sell $$292.34M
Ratio1:188.23
Hardware, Equipment & Parts
Buys2
Sells151
Buy $$251.39K
Sell $$275.33M
Ratio1:1095.23
% Change vs. Prior
Ratio -100.0%Value -80.0%
Transactions (8648)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
360
Price
$518.82
Total Value
$186.78K
Shares Held After
46,800
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
780
Price
$517.94
Total Value
$403.99K
Shares Held After
47,160
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,617
Price
$516.93
Total Value
$835.87K
Shares Held After
47,940
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,360
Price
$515.93
Total Value
$701.67K
Shares Held After
49,557
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,795
Price
$514.82
Total Value
$924.11K
Shares Held After
50,917
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
760
Price
$512.92
Total Value
$389.82K
Shares Held After
52,712
% of Holdings
1.4%
NETFLIX INC (NFLX)
Peters Gregory K — Director
Shares
27,312
Price
$73.54
Total Value
$2.01M
Shares Held After
120,931
% of Holdings
18.4%
Velocity Financial, Inc. (VEL)
Szczepaniak Mark R — Chief Financial Officer
Shares
400
Price
$18.00
Total Value
$7.20K
Shares Held After
66,400
% of Holdings
0.6%
Burke&Herbert Financial Services Corp. (BHRB)
McLaughlin Shawn Patrick — Director
Shares
1,000
Price
$73.25
Total Value
$73.25K
Shares Held After
71,000
% of Holdings
1.4%
Rhinebeck Bancorp, Inc. (RBKB)
Vitale Michael — EVP, Head of Comm Banking
Shares
4,834
Price
$12.35
Total Value
$59.70K
Shares Held After
22,414
% of Holdings
21.6%
WILSON BANK HOLDING CO (WBHC)
CLEMONS JAMES RANDALL — Director
Shares
2,982
Price
$83.45
Total Value
$248.85K
Shares Held After
116,090
% of Holdings
2.6%
FARMERS NATIONAL BANC CORP /OH/ (FMNB)
Wenick Mark J — SEVP/Chief Wealth Mgt Officer
Shares
5,000
Price
$15.97
Total Value
$79.85K
Shares Held After
32,020
% of Holdings
13.5%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
6,975
Price
$44.44
Total Value
$309.97K
Shares Held After
0
% of Holdings
100.0%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
25
Price
$46.56
Total Value
$1.16K
Shares Held After
6,975
% of Holdings
0.4%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
672
Price
$22.02
Total Value
$14.80K
Shares Held After
74,870
% of Holdings
0.9%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
753
Price
$21.97
Total Value
$16.54K
Shares Held After
75,542
% of Holdings
1.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$22.11
Total Value
$2.21K
Shares Held After
76,295
% of Holdings
0.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
480
Price
$21.55
Total Value
$10.34K
Shares Held After
76,395
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.10
Total Value
$4.42K
Shares Held After
76,875
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
3,402
Price
$22.02
Total Value
$74.91K
Shares Held After
77,075
% of Holdings
4.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,556
Price
$22.06
Total Value
$34.33K
Shares Held After
80,477
% of Holdings
1.9%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
82,033
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,332
Price
$22.03
Total Value
$29.34K
Shares Held After
82,233
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
447
Price
$21.87
Total Value
$9.78K
Shares Held After
83,565
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
988
Price
$22.03
Total Value
$21.77K
Shares Held After
84,012
% of Holdings
1.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
85,000
Price
$21.00
Total Value
$1.78M
Shares Held After
85,000
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
Showing 851–900 of 8648 transactions (page 18 of 173)